Clinical Trials Browser

Hodgkin Disease × liposomal doxorubicin × 30 days × Clear all

NCT07021989 2026-06-04

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

Phase 2 Not yet recruiting

Hodgkin Disease